Baader Bank Aktiengesellschaft Castle Biosciences Inc Call Options Transaction History
Baader Bank Aktiengesellschaft
- $1.27 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding CSTL
# of Institutions
192Shares Held
25.4MCall Options Held
9.5KPut Options Held
5K-
Black Rock Inc. New York, NY3.04MShares$50.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$33.7 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$24.2 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.27MShares$20.9 Million2.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$19.8 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $433M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...